167 related articles for article (PubMed ID: 28926735)
1. Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection.
Fassauer GM; Hofstetter R; Hasan M; Oswald S; Modeß C; Siegmund W; Link A
J Pharm Biomed Anal; 2017 Nov; 146():410-419. PubMed ID: 28926735
[TBL] [Abstract][Full Text] [Related]
2. Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
Hasan M; Hofstetter R; Fassauer GM; Link A; Siegmund W; Oswald S
J Pharm Biomed Anal; 2017 May; 139():87-97. PubMed ID: 28279931
[TBL] [Abstract][Full Text] [Related]
3. Supercritical fluid extraction (SFE) of ketamine metabolites from dried urine and on-line quantification by supercritical fluid chromatography and single mass detection (on-line SFE-SFC-MS).
Hofstetter R; Fassauer GM; Link A
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1076():77-83. PubMed ID: 29406031
[TBL] [Abstract][Full Text] [Related]
4. Subcritical Fluid Chromatography at Sub-Ambient Temperatures for the Chiral Resolution of Ketamine Metabolites with Rapid-Onset Antidepressant Effects.
Hofstetter RK; Potlitz F; Schulig L; Kim S; Hasan M; Link A
Molecules; 2019 May; 24(10):. PubMed ID: 31109124
[TBL] [Abstract][Full Text] [Related]
5. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
[TBL] [Abstract][Full Text] [Related]
6. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain.
Toki H; Yamaguchi JI; Mizuno-Yasuhira A; Endo H
J Pharm Biomed Anal; 2023 Feb; 224():115168. PubMed ID: 36473323
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression.
Zhao X; Venkata SL; Moaddel R; Luckenbaugh DA; Brutsche NE; Ibrahim L; Zarate CA; Mager DE; Wainer IW
Br J Clin Pharmacol; 2012 Aug; 74(2):304-14. PubMed ID: 22295895
[TBL] [Abstract][Full Text] [Related]
8. Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.
Moaddel R; Abdrakhmanova G; Kozak J; Jozwiak K; Toll L; Jimenez L; Rosenberg A; Tran T; Xiao Y; Zarate CA; Wainer IW
Eur J Pharmacol; 2013 Jan; 698(1-3):228-34. PubMed ID: 23183107
[TBL] [Abstract][Full Text] [Related]
9. Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats.
Moaddel R; Sanghvi M; Ramamoorthy A; Jozwiak K; Singh N; Green C; O'Loughlin K; Torjman M; Wainer IW
J Pharm Biomed Anal; 2016 Aug; 127():3-8. PubMed ID: 27017097
[TBL] [Abstract][Full Text] [Related]
10. CE provides evidence of the stereoselective hydroxylation of norketamine in equines.
Schmitz A; Theurillat R; Lassahn PG; Mevissen M; Thormann W
Electrophoresis; 2009 Aug; 30(16):2912-21. PubMed ID: 19653235
[TBL] [Abstract][Full Text] [Related]
11. (2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice.
Yamaguchi JI; Toki H; Qu Y; Yang C; Koike H; Hashimoto K; Mizuno-Yasuhira A; Chaki S
Neuropsychopharmacology; 2018 Aug; 43(9):1900-1907. PubMed ID: 29802366
[TBL] [Abstract][Full Text] [Related]
12. Now is the time for (2R,6R)-hydroxynorketamine to be viewed independently from its parent drug.
Chaki S; Yamaguchi JI
Pharmacol Biochem Behav; 2018 Dec; 175():24-26. PubMed ID: 30201385
[No Abstract] [Full Text] [Related]
13. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Zarate CA; Brutsche N; Laje G; Luckenbaugh DA; Venkata SL; Ramamoorthy A; Moaddel R; Wainer IW
Biol Psychiatry; 2012 Aug; 72(4):331-8. PubMed ID: 22516044
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
Hashimoto K
Biochem Pharmacol; 2020 Jul; 177():113935. PubMed ID: 32224141
[TBL] [Abstract][Full Text] [Related]
15. NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Zanos P; Moaddel R; Morris PJ; Georgiou P; Fischell J; Elmer GI; Alkondon M; Yuan P; Pribut HJ; Singh NS; Dossou KS; Fang Y; Huang XP; Mayo CL; Wainer IW; Albuquerque EX; Thompson SM; Thomas CJ; Zarate CA; Gould TD
Nature; 2016 May; 533(7604):481-6. PubMed ID: 27144355
[TBL] [Abstract][Full Text] [Related]
16. Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model.
Zhang K; Toki H; Fujita Y; Ma M; Chang L; Qu Y; Harada S; Nemoto T; Mizuno-Yasuhira A; Yamaguchi JI; Chaki S; Hashimoto K
Psychopharmacology (Berl); 2018 Nov; 235(11):3177-3185. PubMed ID: 30215218
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis.
Sandbaumhüter FA; Theurillat R; Bektas RN; Kutter APN; Bettschart-Wolfensberger R; Thormann W
J Chromatogr A; 2016 Oct; 1467():436-444. PubMed ID: 27485149
[TBL] [Abstract][Full Text] [Related]
18. Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.
Shirayama Y; Hashimoto K
Int J Neuropsychopharmacol; 2018 Jan; 21(1):84-88. PubMed ID: 29155993
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor.
Sałat K; Siwek A; Starowicz G; Librowski T; Nowak G; Drabik U; Gajdosz R; Popik P
Neuropharmacology; 2015 Dec; 99():301-7. PubMed ID: 26240948
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantification of acidic and basic flupirtine metabolites by supercritical fluid chromatography according to European Medicines Agency validation.
Hofstetter RK; Hasan M; Fassauer GM; Bock C; Surur AS; Behnisch S; Grathwol CW; Potlitz F; Oergel T; Siegmund W; Link A
J Chromatogr A; 2019 Oct; 1603():338-347. PubMed ID: 31056272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
